Mark Dearden is an experienced life science executive, board member, angel investor, and advisor/mentor. Currently serving as the President and CEO of Specac Ltd, Dearden also holds positions with England Lacrosse, Manchester Angels, Qincade, and DeciBio, while advising Imperagen. They have a proven track record of aligning shareholders, driving M&A strategies, and fostering high-growth technology businesses in the UK. Dearden earned their degree from the University of Warwick - Warwick Business School between 2006 and 2009.
Location
Altrincham, United Kingdom
This person is not in the org chart
This person is not in any teams
This person is not in any offices